XOMA Royalty Merger Officially Completed on July 14
XOMA Royalty Holdings completed its merger with XOMA Royalty Corporation on July 14. The transaction concluded with the cessation of common stock trading the previous day.
View filing at SEC.gov →4 most recent filings and news items mentioning XOMA. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/XOMA/news?limit=20"
Pull XOMA filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayXOMA Royalty Holdings completed its merger with XOMA Royalty Corporation on July 14. The transaction concluded with the cessation of common stock trading the previous day.
View filing at SEC.gov →Ligand Pharmaceuticals completed the acquisition of XOMA Royalty for $39.00 per share following the deal's closing. The transaction includes a contingent value right for pending litigation proceeds.
View filing at SEC.gov →XOMA Royalty Corporation declared quarterly dividends on its Series A and Series B Preferred Stock, with redemption of all outstanding preferred shares at $25 per share on July 14, 2026. The redemption is tied to the pending merger with Ligand Pharmaceuticals, with CVR distributi
View filing at SEC.gov →XOMA Royalty Corporation amended its bylaws to opt out of Nevada acquiring company statutes and designate Nevada courts as the exclusive forum for internal disputes, while federal courts handle federal securities claims. The amendments limit shareholder litigation venues and redu
View filing at SEC.gov →